These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

534 related items for PubMed ID: 16344320

  • 21. PEFG (cisplatin, epirubicin, 5-fluorouracil, gemcitabine) regimen as second-line therapy in patients with progressive or recurrent pancreatic cancer after gemcitabine-containing chemotherapy.
    Reni M, Cereda S, Mazza E, Passoni P, Nicoletti R, Balzano G, Zerbi A, Arcidiacono PG, Staudacher C, Di Carlo V.
    Am J Clin Oncol; 2008 Apr; 31(2):145-50. PubMed ID: 18391598
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. A phase I study of erlotinib in combination with gemcitabine and radiation in locally advanced, non-operable pancreatic adenocarcinoma.
    Duffy A, Kortmansky J, Schwartz GK, Capanu M, Puleio S, Minsky B, Saltz L, Kelsen DP, O'Reilly EM.
    Ann Oncol; 2008 Jan; 19(1):86-91. PubMed ID: 17878176
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Phase II trial of gemcitabine, epirubicin and granulocyte colony-stimulating factor in patients with advanced pancreatic adenocarcinoma.
    Scheithauer W, Kornek GV, Raderer M, Hejna M, Valencak J, Miholic J, Kovats E, Lang F, Funovics J, Bareck E, Depisch D.
    Br J Cancer; 1999 Aug; 80(11):1797-802. PubMed ID: 10468299
    [Abstract] [Full Text] [Related]

  • 26. Fixed dose rate infusion of gemcitabine with oral doxifluridine and leucovorin for advanced unresectable pancreatic cancer: a phase II study.
    Kim H, Park JH, Shin SJ, Kim MJ, Bang SJ, Park NH, Nah YW, Nam CW, Joo KR, Min YJ.
    Chemotherapy; 2008 Aug; 54(1):54-62. PubMed ID: 18073472
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. [Efficacy of gemcitabine-based chemotherapy on advanced pancreatic cancer].
    Gong JF, Zhang XD, Li J, Di LJ, Jin ML, Shen L.
    Ai Zheng; 2007 Aug; 26(8):890-4. PubMed ID: 17697554
    [Abstract] [Full Text] [Related]

  • 29. A phase I study of full-dose gemcitabine and regional arterial infusion of nafamostat mesilate for advanced pancreatic cancer.
    Uwagawa T, Misawa T, Sakamoto T, Ito R, Gocho T, Shiba H, Wakiyama S, Hirohara S, Sadaoka S, Yanaga K.
    Ann Oncol; 2009 Feb; 20(2):239-43. PubMed ID: 18836085
    [Abstract] [Full Text] [Related]

  • 30. Gemcitabine and cisplatin treatment of advanced-stage non-small-cell lung cancer in patients given cisplatin on day 8.
    Akcali Z, Calikusu Z, Sakalli H, Ozyilkan O.
    Tumori; 2008 Feb; 94(4):474-80. PubMed ID: 18822681
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Gemcitabine and protracted 5-FU for advanced pancreatic cancer. A phase II study.
    Kurtz JE, Kohser F, Négrier S, Trillet-Lenoir V, Walter S, Limacher JM, Untereiner M, Kayitalire L, Jaeck D, Dufour P.
    Hepatogastroenterology; 2000 Feb; 47(35):1450-3. PubMed ID: 11100374
    [Abstract] [Full Text] [Related]

  • 33. Phase II study of gemcitabine in combination with cisplatin in patients with locally advanced and/or metastatic pancreatic cancer.
    Brodowicz T, Wolfram RM, Köstler WJ, Tomek S, Vaclavik I, Steger GG, Teleky B, Függer R, Jakesz R, Zielinski CC.
    Anticancer Drugs; 2000 Sep; 11(8):623-8. PubMed ID: 11081453
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Phase I-II study of gemcitabine and fluorouracil as a continuous infusion in patients with pancreatic cancer.
    Hidalgo M, Castellano D, Paz-Ares L, Gravalos C, Diaz-Puente M, Hitt R, Alonso S, Cortes-Funes H.
    J Clin Oncol; 1999 Feb; 17(2):585-92. PubMed ID: 10080603
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. A phase I study of the biomodulation of capecitabine by docetaxel and gemcitabine (mGTX) in previously untreated patients with metastatic adenocarcinoma of the pancreas.
    Hill ME, Li X, Kim S, Campbell A, Culler K, Bloomston M, Zalupski M, Hejna G, Bekaii-Saab T.
    Cancer Chemother Pharmacol; 2011 Mar; 67(3):511-7. PubMed ID: 20461379
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 27.